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rated by SDS-PAGE, transferred to PVDF membranes, and probed by FFGV
(BC-14), IPEN and TEGE neoepitope antibodies, and by antibodies against
aggrecan G1 and G3 domains. Immunodetected aggrecan fragments were
quantiﬁed using chemiluminescence and digital luminescence imager. N-
and C-terminal ends not veriﬁed by immunodetection where estimated
using a calculation model.
Results: The Western blot results showed that MMP-3 cleaves aggrecan in
several sites in six separate regions (a–f, Fig. 1). Time dependent kinetic
studies showed that the most preferred MMP cuts in aggrecan were in
region a, e and f. The second most preferred cut occurred in region d,
while cuts in region b and c were the least preferred. Also, in both young
(knee healthy) and adult (OA) cartilage, Western blot quantiﬁcation of the
in vivo MMP-generated G1-IPEN fragment was 3 times lower (mol/mol)
compared to the in vivo aggrecanase generated G1-TEGE fragment. Except
for the common G1-IPEN other fragments were detected in cartilage in vivo
(G1-CS1, 210-245 kDa) and in OA synovial ﬂuid (ARGS-CS1, 130-160 kDa;
CS1-KEEE 125 kDa) with suggested N- and C-terminals from MMP cuts in
the CS1 region.
Figure 1. Several MMP cleavage sites were found in six regions (a–f) in human aggrecan.
OA cartilage (A1D1) was in vitro digested by MMP-3 and fragments were visualized by
Western blot. Illustration of human aggrecan, MMP cleavage sites and MMP-3 in vitro
generated fragments (Mw in kDA).
Conclusions: There are at least 24 potentially MMP cleavage sites in the
CS1 domain but our results suggest that only a few sites, in the beginning
and in the end of this domain, are available for MMP proteolysis. Two of
the MMP cuts, in the IGD and in the KS region, results in loss of most of the
glycosaminoglycans from aggrecan and thereby loss of cartilage resilience.
Quantiﬁcation of in vivo generated G1-IPEN and G1-TEGE fragments indi-
cate signiﬁcant contribution of MMP proteolysis against aggrecan in both
young (knee healthy) and adult (OA) cartilage.
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Purpose: Molecules that are released into biological ﬂuids during matrix
metabolism and/or cellular activity in articular cartilage, subchondral bone,
and synovial tissue could serve as biochemical markers of the process of
osteoarthritis (OA). Unfortunately, actual breakthroughs in the biochemical
OA marker ﬁeld are limited so far. Critical evaluation of knowledge on the
performance of currently available biochemical OA markers could guide
and stimulate further biochemical OA marker research. Therefore, biochem-
ical OA marker performance was systematically reviewed according to the
“BIPED” classiﬁcation, as published in 2006 in O&C.
Methods: PubMed, Scopus and EMBASE were systematically searched for
publications on blood and urinary biochemical markers in human primary
knee and hip OA. 84 relevant publications were identiﬁed. Data were
scored and tabulated according to the “BIPED” classiﬁcation.
Results: 26 biochemical OA markers were scored according to the “BIPED”
classiﬁcation structure. Comparison of individual biochemical marker per-
formance was hampered by an uneven distribution of “BIPED” scores;
uCTX-II and sCOMP were investigated most extensively. Also, studies
showed heterogenic designs. The majority of studies involved relatively
small cohorts and/or a cross-sectional design. Therefore, comparison of
categories of biochemical markers was performed instead. Biochemical
markers of cartilage degradation were investigated most extensively and
performed well in comparison with other categories. Biochemical mark-
ers of bone metabolism performed less adequately. Biochemical markers
of synovial tissue activity were investigated minimally, but performed
relatively well.
Conclusions: This systematic review shows that there is a lack of consis-
tent, high-quality evidence for the vast majority of commercially available
biochemical OA markers. This lack of interest for some of the markers is not
necessarily supported by publications showing their limited applicability.
Additional investigation of biochemical OA markers in large-scale and/or
longitudinal cohort studies is crucial to increase our knowledge on the
applicability of these markers. Importantly, also the nature, origin and
metabolism of biochemical markers need further investigation. Interna-
tional standardization of such future investigations should be pursued
to obtain more high-quality, homogenous data on the full spectrum of
biochemical markers. Finally, all involved parties should realize that most
biochemical markers are still in an explorative stage and publication bias is
therefore undesirable and should be prevented.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an initiative
of the Dutch Arthritis Association.
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Purpose: To explore prognostication of incident radiographic osteoarthritis
(OA) at the knee with OA-related biomarkers: cartilage oligomeric ma-
trix protein (COMP), hyaluronan (HA), high-sensitivity C-reactive protein
(hsCRP), and keratan sulfate (KS) in a large, community-based sample.
Methods: Baseline serum biomarkers of COMP,and KS were measured
using in-house sandwich enzyme linked immunosorbent assays, HA was
measured with the Hylauronic Acid Test kit, and hsCRP was measured with
the UBI Magiwel Enzyme Immunoassay for 803 participants recruited from
1991-1997 in the Johnston County Osteoarthritis Project. Follow-up assess-
ments were completed from 1999-2003 (mean = 6.3 years; range= 3.0 - 10.2
years). Linked baseline and follow-up anterior-posterior radiographs with
weight-bearing and footmat positioning were read for Kellgren-Lawrence
(KL) grade (0-4) and osteophyte (OST) and joint space narrowing (JSN;
both 0-3 with Burnett atlas). Three incident radiographic OA outcomes
were explored and deﬁned as: 1) a KL grade of 0-1 at baseline and ≥2 at
follow-up, 2) an OST grade=0 at baseline and ≥1 at follow-up, and 3) a
JSN grade=0 at baseline and ≥1 at follow-up. Five hundred forty two knees
were at risk for incident OA by KL grades (KL grade of 0-1 at baseline),
349 knees at risk for incident OST formation (OST=0 at baseline), and
440 knees at risk for incident JSN (JSN=0 at baseline). For each outcome,
Cox regression models were used to estimate the hazard ratio (HR) for
a 1-unit increase in the natural log of each biomarker, adjusting for age,
race, gender, and body mass index and accounting for bilateral clustering
of knees using robust variance estimates. History of lower extremity injury
(knee or hip injury or fracture) and chronic knee symptoms were explored
as potential modiﬁers of the association.
Results: In adjusted models, the hazard of incident knee OA by KL and
OST increased with higher baseline lnCOMP levels (adjusted HR [aHR]
= 1.46, 95% conﬁdence interval [CI] = 0.96-2.23, and aHR= 2.26, 95% CI
=1.45-3.53, respectively). The hazard of incident knee JSN also increased
with higher lnCOMP levels (aHR=2.14, 95% CI= 1.32-3.47) and higher lnHA
levels (aHR=1.63, 95% CI= 1.26-2.12). In unstratiﬁed analyses, higher levels
of lnhsCRP and lnKS did not predict the incident knee outcomes. Neither
history of lower extremity injury nor chronic knee symptoms was a strong
modiﬁer of these associations (p > 0.10). However, a pattern was observed
of higher adjusted HRs for lnCOMP, lnHA, and, most notably, for lnKS with
